Gebhart CL, Kabanov AV. Evaluation of polyplexes as gene transfer agents. J Control Release 2001, 73, 401-416.

Goula D, Remy JS, Erbacher P, Wasowicz M, Levi G, Abdalkan B, Demeneix BA. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Therapy 1998, 5, 712-717.

Segura T, Shea LD. Materials for nonviral gene delivery. Annu Rev Mater Res 2001, 31, 25-46.

Lin AJ, Slack NL, Ahmad A, Koltover I, George CX, Samuel CE, Safinya CR. Structure and structure-function studies of lipid/plasmid DNA complexes. J Drug Target 2000, 8, 13-27.

Tang MX, Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther 1997, 4, 823-832.

Bloomfield VA. DNA condensation. Curr Opin Struct Biol 1996, 6, 334-341. Bloomfield VA. DNA condensation by multivalent cations. Biopolymers 1997, 44, 269-282.

Bloomfield VA. Condensation of DNA by multivalent cations: considerations on mechanism. Biopolymers 1991, 31, 1471-1481.

Widom J, Baldwin RL. Cation-induced toroidal condensation of DNA studies with Co3+ (pH3). J Mol Biol 1980, 144, 431-453.

Marschall P, Malik N, Larin Z. Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine. Gene Ther 1999, 6, 1634-1637. Godbey WT, Wu KK, Mikos AG. Poly(ethylenimine) and its role in gene delivery. J Control Release 1999, 60, 149-160.

Kircheis R, Schuller S, Brunner S, Ogris M, Heider KH, Zauner W, Wagner E. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med 1999, 1, 111-120.

Ogris M, Steinlein P, Kursa M, Mechtler K, Kircheis R, Wagner E. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther 1998, 5, 1425-1433.

Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 1996, 3, 1074-1080. Ross PC, Hui SW. Lipoplex size is major determinant of in vitro lipofection efficiency. Gene Ther 1999, 6, 651-659.

McLean JW, Fox EA, Baluk P, Bolton PB, Haskell A, Pearlman R, Thurston G, Umemoto EY, McDonald DM. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol 1997, 273, H387-H404. Song YK, Liu F, Chu S, Liu D. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther 1997, 8, 1585- 1594.

Godbey WT, Wu KK, Mikos AG. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci USA 1999, 96, 5177-5181.

Pollard H, Remy JS, Loussouarn G, Demolombe S, Behr JP, Escande D. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem 1998, 273, 7507-7511.

Suh J, Wirtz D, Hanes J. Efficient active transport of gene nanocarriers to the cell nucleus. DNAs 2002, 100, 3878-3882.

Jans DA, Chan CK, Huebner S. Signals mediating nuclear targeting and their regulation: application in drug delivery. Med Res Rev 1998, 18, 189-223.

Cone RA. Mucus. In Mucosal Immunology; 2nd ed; Orga PL, ed. Academic Press: San Diego, 1999; 43-64.

Lai E, Van Zanten JH. Evidence of lipoplex dissociation in liquid formulations. J Pharm Sci 2002, 91, 1225-1232.

Lai E, van Zanten JH. Real-time monitoring of lipoplex molar mass, size and density. J Control Release 2002, 82, 149-158.

Lai E, van Zanten JH. Monitoring DNA/poly-l-lysine polyplex formation with time-resolved multiangle laser light scattering. Biophys J 2001, 80, 864-873. Har-el Y, van Zanten JH, Hanes J. PEI/VEGF DNA polyplexes: effects of serum and solvent on vector size, molar mass, and transfection efficiency, in preparation. Har-el Y, van Zanten JH, Hanes J. Effect of formulation parameters on PEI/VEGF DNA polyplex physical properties determined using time-resolved multiangle laser light scattering, in preparation.

Lemkine GF, Demeneix BA. Polyethylenimines for in vivo gene delivery. Curr Opin Mol Ther 2001, 3, 178-182.

Nabel EG, Gordon D, Yang ZY, Xu L, San H, Plautz GE, Wu BY, Gao X, Huang L, Nabel GJ. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Hum Gene Ther 1992, 3, 649-656. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993, 90, 11307-11311.

Caplen NJ, Alton EW, Middleton PG, Dorin JR, Stevenson BJ, Gao X, Durham SR, Jeffrey PK, Hodson ME, Coutelle C, et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1995, 1, 39-46. Gustafsson J, Arvidson G, Karlsson G, Almgren M. Complexes between cationic liposomes and DNA visualized by cryo-TEM. Biochim Biophys Acta 1995, 1235, 305-312.

Li B, Li S, Tan Y, Stolz DB, Watkins SC, Block LH, Huang L. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. J Pharm Sci 2000, 89, 355-364. Quraishi MS, Jones NS, Mason J. The rheology of nasal mucus: a review. Clin Otolaryngol 1998, 23, 403-413.

Bastacky J, Lee CY, Goerke J, Koushafar H, Yager D, Kenaga L, Speed TP, Chen Y, Clements JA. Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol 1995, 79, 1615-1628. Hanes J, Edwards DA, Evora C, Langer R. Particles incorporating surfactants for pulmonary drug delivery. U.S. Patent No. 5,855,913, 1999. Sanders NN, Van Rompaey E, De Smedt SC, Demeester J. Structural alterations of gene complexes by cystic fibrosis sputum. Am J Respir Crit Care Med 2001, 164, 486-493.

Kitson C, Angel B, Judd D, Rothery S, Severs NJ, Dewar A, Huang L, Wadsworth SC, Cheng SH, Geddes DM, Alton EW. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther 1999, 6, 534-546.

Willits RK, Saltzman WM. Synthetic polymers alter the structure of cervical mucus. Biomaterials 2001, 22, 445-452.

Khanvilkar K, Donovan MD, Flanagan DR. Drug transfer through mucus. Adv Drug Deliv Rev 2001, 48, 173-193.

Gonda I. Inhalation therapy with recombinant human deoxyribonuclease I. Adv Drug Deliv Rev 1996, 19, 37-46.

Rubin B. Emerging therapies for cystic fibrosis lung disease. Chest 1999, 115, 1120-1126.

Silberberg A. Models of Mucus Structure; Raven Press: New York, 1988. Sanders N, De Smedt S, Demeester J. The physical properties of biogels and their permeability for macromolecular drugs and colloidal drug carriers. J Pharm Sci 1999, 89, 835-849.

Yudin AI, Hanson FW, Katz DF. Human cervical mucus and its interaction with sperm: a fine-structural view. Biol Reprod 1989, 40, 661-671. Sanders NN, De Smedt SC, Van Romaey E, Simoens P, De Baets F, Demeester J. Cystic fibrosis sputum: a barrier to the transport of nanospheres. Am J Respir Crit Care Med 2000, 162, 1905-1911.

Bhat PG, Flanagan DR, Donovan MD. Drug diffusion through cystic fibrotic mucus: steady-state permeation, rheologic properties, and glycoprotein morphology. J Pharm Sci 1996, 85, 624-630.

Wu-Pong S, Byron P. Airway to biophase transfer of oligonucleotides. Adv Drug Del Rev 1996, 19, 47-71.

Rubin B. Therapeutic aerosols and airway secretions. J Aerosol Med 1996, 9, 123-130.

Lele BS, Hoffman AS. Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. J Control Release 2000, 69, 237-248.

Zahm JM, Galabert C, Chaffin A, Chazalette JP, Grosskopf C, Puchelle E. Improvement of cystic fibrosis airway mucus transportability by recombinant human DNase is related to changes in phospholipid profile. AM J Respir Crit Care Med 1998, 157, 1779-1784.

De Smedt S, Meyvis E, van Oostveldt P, Blonk J, Hennink W, Demeester J. The diffusion of macromolecules in dextran methacrylate solutions and gels as studied by confocal scanning laser microscopy. Macromolecules 1997, 30, 4863 -4870. Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J 2001, 81, 1930-1937.

Banerjee R, Bellare J, Puniyani R. Effect of phospholipid mixtures and surfactant formulations on rheology of polymeric gels, simulating mucus, at shear rates experienced in the tracheobronchial tree. Biochem Eng J 2001, 7, 195-200. Girod S, Zahm JM, Plotkowski C, Beck G, Puchelle E. Role of the physiochemical properties of mucus in the protection of the respiratory epithelium. Eur Respir J 1992, 5, 477-487.

Norris D, Sinko P. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J Appl Polym Sci 1996, 63, 1481-1492.

Mrsny R, Daugherty A, Short S, Widmer R, Siegel M, Keller G. Distribution of DNA and alginate in purulent cystic fibrosis sputum: implications to pulmonary targeting strategies. J Drug Targeting 1996, 4, 233-243.

Sisson JH, Yonkers AJ, Waldman RH. Effects of guaifenesin on nasal mucociliary clearance and ciliary beat frequency in healthy volunteers. Chest 1995, 107, 747-751.

Lusuardi M, Donner C. Glycoproteins; Raven Press: New York, 1998. Vasconcellos CA. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 2002, 263, 969-971.

Cruewels L, Golde L, Haagsman H. The pulmonary surfactant system: Biochemical and clinical aspects. Lung 1997, 175, 1-39.

LeVine AM, Whitsett JA. Pulmonary collectins and innate host defense of the lung. Microbes Infect 2001, 3, 161-166.

van Iwaarden JF, Pikaar JC, Storm J, Brouwer E, Verhoef J, Oosting RS, van Golde LM, van Strijp JA. Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides. Biochem J 1994, 303, 407-411.

LeVine AM, Whitsett JA, Hartshorn KL, Crouch EC, Korfhagen TR. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001, 167, 5868-5873.

Pruitt K, Rahemtulla B, Rahemtulla F, Russell M. Innate Humoral Factors. In Mucosal Immunology; Orga PL, ed. Academic Press: San Diego, 1999; 65-88. Pryhuber GS. Regulation and function of pulmonary surfactant protein B. Mol Genet Metab 1998, 64, 217-228.

Tabata Y, Ikada Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 1988, 9, 356-362. Dinghua L, Lancaster J, Mahesh S, Nelson S, Stoltz D, Bagby G, Odom G, Shellito J, Kolls J. Activation of alveolar macrophages and lung host defenses using transfer of the interferon-gamma gene. Am J Physiology 1997, 272, L852-L859. Baatz JE, Zou Y, Korfhagen TR. Inhibitory effects of tumor necrosis factor-alpha on cationic lipid-mediated gene delivery to airway cells in vitro. Biochim Biophys Acta 2001, 1535, 100-109.

Zsengeller Z, Otake K, Hossain SA, Berclaz PY, Trapnell BC. Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection. J Virol 2000, 74, 9655 -9667. Zuber G, Dauty E, Nothisen M, Belguise P, Behr JP. Towards synthetic viruses. Adv Drug Deliv Rev 2001, 52, 245-253.

Apgar J, Tseng Y, Fedorov E, Herwig MB, Almo SC, Wirtz D. Multiple-particle tracking measurements of heterogeneities in solutions of actin filaments and actin bundles. Biophys J 2000, 79, 1095-1106.

Mislick KA, Baldeschwieler JD. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci USA 1996, 93, 12349-12354.

Mounkes LC, Zhong W, Cipres-Palacin G, Heath TD, Debs RJ. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J Biol Chem 1998, 273, 26164-26170.

Baranowski E, Ruiz-Jarabo CM, Domingo E. Evolution of cell recognition by viruses. Science 2001, 292, 1102-1105.

Schaffer DV, Lauffenburger DA. Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery. J Biol Chem 1998, 273, 28004-28009.

Zenke M, Steinlein P, Wagner E, Cotten M, Beug H, Birnstiel ML. Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. Proc Natl Acad Sci USA 1990, 87, 3655-3659.

Wagner E, Zenke M, Cotten M, Beug H, Brinstiel ML. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 1990, 87, 3410-3414.

Erbacher P, Remy JS, Behr JP. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther 1999, 6, 138-145. Scott ES, Wiseman JW, Evans MJ, Colledge WH. Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J Gene Med 2001, 3, 125-134.

Colin M, Harbottle RP, Knight A, Kornprobst M, Cooper RG, Miller AD, Trugnan G, Capeau J, Coutelle C, Brahimi-Horn MC. Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells. Gene Ther 1998, 5, 1488-1498.

Kim J, Smith T, Idamakanti N, Mulgrew K, Kaloss M, Kylefjord H, Ryan PC, Kaleko M, Stevenson SC. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization. J Virol 2002, 76, 1892-1903.

Fajac I, Grosse S, Briand P, Monsigny M. Targeting of cell receptors and gene transfer efficiency: a balancing act. Gene Ther 2002, 9, 740-742. James MB, Giorgio TD. Nuclear-associated plasmid, but not cell-associated plasmid, is correlated with transgene expression in cultured mammalian cells. Mol Ther 2000, 1, 339-346.

Pickles RJ, McCarty D, Matsui H, Hart PJ, Randell SH, Boucher RC. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol 1998, 72, 6014-6023.

Fasbender A, Zabner J, Zeiher BG, Welsh MJ. A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia. Gene Ther 1997, 4, 1173-1180.

Zelphati O, Szoka FC, Jr. Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci USA 1996, 93, 11493-11498.

Hafez IM, Maurer N, Cullis PR. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther 2001, 8,

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment